Home Search
Sanofi - search results
If you're not happy with the results, please do another search
Sanofi Recalls Auvi-Q for Potential Inaccurate Dosage Delivery
Sanofi US is voluntarily recalling all Auvi-Q because the products have been found to potentially have inaccurate dosage delivery. The recall involves all Auvi-Q...
Sanofi: LixiLan Trial Showed Superior Reduction in HbA1c vs Insulin Glargine Alone
Sanofi is reporting positive results in their second pivotal LixiLan Phase III study. LixiLan could provide a treatment option for diabetes patients who are...
New FDA-Approved Diabetes Medicine Might Save Sanofi
Sanofi may have been having financial trouble in recent years, but a newly approved diabetes drug might be just the help they needed. https://www.youtube.com/watch?v=a0xhwv2DUJM
Plan to Combat Soaring Insulin Costs Proposed to Lower Costs for Diabetics
A new proposal details how insulin costs can be lowered for diabetics, and the top 3 insulin manufacturers are taking steps to make insulin less expensive.
Partnership Combines Diabetes Digital Therapeutic Offerings Between Voluntis and WellDoc
New agreement will combine Voluntis’ insulin titration technology with WellDoc’s extensive digital coaching platform to create a holistic digital diabetes management solution for patients, providers, health systems and health plans.
Treatment Change to Prevent Heart Disease for Type 2 Diabetes Patients
Four clinical trials have led researchers to call for a shift in diabetes treatment that includes medications to lower the risk of heart disease in type 2 diabetes patients.
Promising Method to Treat All Forms of Diabetes Found
Findings in human, mouse and zebrafish beta cells suggest a promising method to help treat all forms of diabetes, according to researchers at Joslin...
Diabetic Enteropathy Cause, Treatment and Possible Prevention Discovered
Diabetic enteropathy - with gastrointestinal symptoms like abdominal pain, bloating and nausea - may soon be preventable and treatable. Exciting news considering that it...
Lixisenatide, a New Diabetes Drug, Had No Increase in Cardiovascular Risk
Cardiovascular safety of a new glucose-lowering drug, named Lixisenatide, has been observed by Brigham and Women's Hospital researchers. An international, multidisciplinary team including investigators from...
